Investors
Press releases
YEAR:
ALL
- All
TYPE:
ALL
- All
- Regulatory
- Non Regulatory
2022
February 23, 2022
/ Non Regulatory
Invitation to IRLAB’s Capital Markets Day 2022– Insights into our growth strategy
Read more
February 23, 2022
/ Non Regulatory
Inbjudan till IRLAB:s kapitalmarknadsdag 2022 – Insikter om vår tillväxtstrategi
Read more
February 23, 2022
/ Regulatory
IRLAB’s year-end report January 1 – December 31, 2021
Read more
February 23, 2022
/ Regulatory
IRLAB bokslutskommuniké januari – december 2021
Read more
February 16, 2022
/ Non Regulatory
Invitation to the presentation of IRLAB´s year-end report January – December 2021
Read more
February 16, 2022
/ Non Regulatory
Inbjudan till telefonkonferens i samband med IRLAB´s bokslutskommuniké för 2021
Read more2021
December 31, 2021
/ Regulatory
Board member leaves IRLAB for another assignment
Read more
December 31, 2021
/ Regulatory
Styrelseledamot lämnar IRLAB:s styrelse för nytt uppdrag
Read more
December 21, 2021
/ Regulatory
IRLAB obtains regulatory approval to conduct Phase IIb study with pirepemat – one step closer to improving balance and reducing fall injuries for people living with Parkinson’s disease
Read more
December 21, 2021
/ Regulatory